| Product Code: ETC9959535 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Arthritis Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Arthritis Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Arthritis Market - Industry Life Cycle |
3.4 United States (US) Arthritis Market - Porter's Five Forces |
3.5 United States (US) Arthritis Market Revenues & Volume Share, By Rheumatoid Drug Type, 2021 & 2031F |
3.6 United States (US) Arthritis Market Revenues & Volume Share, By Rheumatoid Treatment, 2021 & 2031F |
3.7 United States (US) Arthritis Market Revenues & Volume Share, By Rheumatoid Diagnosis, 2021 & 2031F |
3.8 United States (US) Arthritis Market Revenues & Volume Share, By Osteoarthritis Type, 2021 & 2031F |
3.9 United States (US) Arthritis Market Revenues & Volume Share, By Osteoarthritis Diagnosis, 2021 & 2031F |
3.10 United States (US) Arthritis Market Revenues & Volume Share, By Osteoarthritis Treatment, 2021 & 2031F |
3.11 United States (US) Arthritis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 United States (US) Arthritis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Aging population leading to a higher prevalence of arthritis |
4.2.2 Technological advancements in arthritis treatment options |
4.2.3 Increasing awareness and focus on preventive healthcare measures |
4.3 Market Restraints |
4.3.1 High cost associated with arthritis medications and treatments |
4.3.2 Regulatory challenges and approval processes for new arthritis drugs |
4.3.3 Limited access to specialized healthcare services in certain regions |
5 United States (US) Arthritis Market Trends |
6 United States (US) Arthritis Market, By Types |
6.1 United States (US) Arthritis Market, By Rheumatoid Drug Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Arthritis Market Revenues & Volume, By Rheumatoid Drug Type, 2021- 2031F |
6.1.3 United States (US) Arthritis Market Revenues & Volume, By Biologics, 2021- 2031F |
6.1.4 United States (US) Arthritis Market Revenues & Volume, By Non-Biologics, 2021- 2031F |
6.1.5 United States (US) Arthritis Market Revenues & Volume, By Steroids, 2021- 2031F |
6.1.6 United States (US) Arthritis Market Revenues & Volume, By Analgesics, 2021- 2031F |
6.1.7 United States (US) Arthritis Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.1.8 United States (US) Arthritis Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Arthritis Market, By Rheumatoid Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Arthritis Market Revenues & Volume, By Synovectomy, 2021- 2031F |
6.2.3 United States (US) Arthritis Market Revenues & Volume, By Tendon Repair, 2021- 2031F |
6.2.4 United States (US) Arthritis Market Revenues & Volume, By Joint Fusion, 2021- 2031F |
6.2.5 United States (US) Arthritis Market Revenues & Volume, By Symptomatic Treatment, 2021- 2031F |
6.2.6 United States (US) Arthritis Market Revenues & Volume, By Intermediate Corticosteroid Therapies, 2021- 2031F |
6.2.7 United States (US) Arthritis Market Revenues & Volume, By DMARD Therapies, 2021- 2031F |
6.3 United States (US) Arthritis Market, By Rheumatoid Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Arthritis Market Revenues & Volume, By C.R.P. Test, 2021- 2031F |
6.3.3 United States (US) Arthritis Market Revenues & Volume, By C.C.P., 2021- 2031F |
6.3.4 United States (US) Arthritis Market Revenues & Volume, By E.S.R. Test, 2021- 2031F |
6.4 United States (US) Arthritis Market, By Osteoarthritis Type |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Arthritis Market Revenues & Volume, By Hip, 2021- 2031F |
6.4.3 United States (US) Arthritis Market Revenues & Volume, By Spinal, 2021- 2031F |
6.4.4 United States (US) Arthritis Market Revenues & Volume, By Knee, 2021- 2031F |
6.4.5 United States (US) Arthritis Market Revenues & Volume, By Foot and Ankle, 2021- 2031F |
6.4.6 United States (US) Arthritis Market Revenues & Volume, By Shoulder, 2021- 2031F |
6.4.7 United States (US) Arthritis Market Revenues & Volume, By Hand, 2021- 2031F |
6.5 United States (US) Arthritis Market, By Osteoarthritis Diagnosis |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Arthritis Market Revenues & Volume, By Imaging, 2021- 2031F |
6.5.3 United States (US) Arthritis Market Revenues & Volume, By Joint Fluid Analysis, 2021- 2031F |
6.5.4 United States (US) Arthritis Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United States (US) Arthritis Market, By Osteoarthritis Treatment |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Arthritis Market Revenues & Volume, By Medication, 2021- 2031F |
6.6.3 United States (US) Arthritis Market Revenues & Volume, By Drugs, 2021- 2031F |
6.6.4 United States (US) Arthritis Market Revenues & Volume, By Assistive Devices, 2021- 2031F |
6.6.5 United States (US) Arthritis Market Revenues & Volume, By Surgery, 2021- 2031F |
6.6.6 United States (US) Arthritis Market Revenues & Volume, By Therapy, 2021- 2031F |
6.7 United States (US) Arthritis Market, By Route of Administration |
6.7.1 Overview and Analysis |
6.7.2 United States (US) Arthritis Market Revenues & Volume, By Oral, 2021- 2031F |
6.7.3 United States (US) Arthritis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.8 United States (US) Arthritis Market, By End-Users |
6.8.1 Overview and Analysis |
6.8.2 United States (US) Arthritis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.8.3 United States (US) Arthritis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.8.4 United States (US) Arthritis Market Revenues & Volume, By Medical Institutes, 2021- 2031F |
6.8.5 United States (US) Arthritis Market Revenues & Volume, By Medical Institutes, 2021- 2031F |
6.8.6 United States (US) Arthritis Market Revenues & Volume, By Research Organizations, 2021- 2031F |
6.8.7 United States (US) Arthritis Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Arthritis Market Import-Export Trade Statistics |
7.1 United States (US) Arthritis Market Export to Major Countries |
7.2 United States (US) Arthritis Market Imports from Major Countries |
8 United States (US) Arthritis Market Key Performance Indicators |
8.1 Average age of arthritis diagnosis in the US population |
8.2 Adoption rate of innovative arthritis treatment technologies |
8.3 Percentage of healthcare providers offering arthritis prevention programs |
8.4 Patient satisfaction with arthritis treatment outcomes |
8.5 Number of research studies and clinical trials focused on arthritis treatments and management |
9 United States (US) Arthritis Market - Opportunity Assessment |
9.1 United States (US) Arthritis Market Opportunity Assessment, By Rheumatoid Drug Type, 2021 & 2031F |
9.2 United States (US) Arthritis Market Opportunity Assessment, By Rheumatoid Treatment, 2021 & 2031F |
9.3 United States (US) Arthritis Market Opportunity Assessment, By Rheumatoid Diagnosis, 2021 & 2031F |
9.4 United States (US) Arthritis Market Opportunity Assessment, By Osteoarthritis Type, 2021 & 2031F |
9.5 United States (US) Arthritis Market Opportunity Assessment, By Osteoarthritis Diagnosis, 2021 & 2031F |
9.6 United States (US) Arthritis Market Opportunity Assessment, By Osteoarthritis Treatment, 2021 & 2031F |
9.7 United States (US) Arthritis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 United States (US) Arthritis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 United States (US) Arthritis Market - Competitive Landscape |
10.1 United States (US) Arthritis Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Arthritis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here